Lataa...
Chimeric Antigen Receptor-Engineered T Cells for Immunotherapy of Cancer
CD4(+) and CD8(+) T lymphocytes are powerful components of adaptive immunity, which essentially contribute to the elimination of tumors. Due to their cytotoxic capacity, T cells emerged as attractive candidates for specific immunotherapy of cancer. A promising approach is the genetic modification of...
Tallennettuna:
| Päätekijät: | , , , , , , , |
|---|---|
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Hindawi Publishing Corporation
2010
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2864912/ https://ncbi.nlm.nih.gov/pubmed/20467460 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2010/956304 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|